Free Trial

Aimei Health Technology (AFJK) Competitors

Aimei Health Technology logo
$11.03 0.00 (0.00%)
As of 05/1/2025

AFJK vs. BIOX, SJT, CEPO, SBXD, RENE, BZAI, NREF, TCI, PINE, and UROY

Should you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include Bioceres Crop Solutions (BIOX), San Juan Basin Royalty Trust (SJT), Cantor Equity Partners I (CEPO), Silverbox Corp IV (SBXD), Cartesian Growth Co. II (RENE), Blaize (BZAI), NexPoint Real Estate Finance (NREF), Transcontinental Realty Investors (TCI), Alpine Income Property Trust (PINE), and Uranium Royalty (UROY). These companies are all part of the "trading" industry.

Aimei Health Technology vs.

Bioceres Crop Solutions (NASDAQ:BIOX) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends.

In the previous week, Bioceres Crop Solutions and Bioceres Crop Solutions both had 3 articles in the media. Aimei Health Technology's average media sentiment score of 1.76 beat Bioceres Crop Solutions' score of 1.02 indicating that Aimei Health Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bioceres Crop Solutions
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aimei Health Technology
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Bioceres Crop Solutions has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Aimei Health Technology has a beta of -0.04, indicating that its stock price is 104% less volatile than the S&P 500.

Bioceres Crop Solutions has higher revenue and earnings than Aimei Health Technology.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bioceres Crop Solutions$407.73M0.67$3.24M$0.02218.00
Aimei Health TechnologyN/AN/A$170KN/AN/A

17.7% of Bioceres Crop Solutions shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 2.3% of Bioceres Crop Solutions shares are held by insiders. Comparatively, 1.7% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bioceres Crop Solutions received 34 more outperform votes than Aimei Health Technology when rated by MarketBeat users.

CompanyUnderperformOutperform
Bioceres Crop SolutionsOutperform Votes
34
79.07%
Underperform Votes
9
20.93%
Aimei Health TechnologyN/AN/A

Bioceres Crop Solutions presently has a consensus target price of $8.63, indicating a potential upside of 97.82%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, analysts clearly believe Bioceres Crop Solutions is more favorable than Aimei Health Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioceres Crop Solutions
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
3.33
Aimei Health Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Bioceres Crop Solutions has a net margin of 0.58% compared to Aimei Health Technology's net margin of 0.00%. Bioceres Crop Solutions' return on equity of 0.68% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Bioceres Crop Solutions0.58% 0.68% 0.28%
Aimei Health Technology N/A N/A N/A

Summary

Bioceres Crop Solutions beats Aimei Health Technology on 12 of the 14 factors compared between the two stocks.

Get Aimei Health Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFJK vs. The Competition

MetricAimei Health TechnologyHolding Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$67.34M$473.79M$3.84B$7.93B
Dividend YieldN/A7.74%4.21%4.22%
P/E RatioN/A2.4113.0518.54
Price / SalesN/A54.241,692.12103.30
Price / Cash500.2069.0150.4934.62
Price / Book-550.003.663.414.25
Net Income$170,000.00$35.22M$1.25B$248.18M
7 Day Performance-0.50%1.56%0.95%1.03%
1 Month Performance0.18%4.34%13.41%2.70%
1 Year Performance6.80%24.28%12.66%4.05%

Aimei Health Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFJK
Aimei Health Technology
N/A$11.03
flat
N/A+6.8%$67.53MN/A0.00N/ANews Coverage
Positive News
BIOX
Bioceres Crop Solutions
2.8877 of 5 stars
$4.28
+4.4%
$8.63
+101.5%
-62.6%$268.40M$407.73M214.11500Positive News
SJT
San Juan Basin Royalty Trust
1.0213 of 5 stars
$5.75
+1.3%
N/A+46.3%$267.77M$6.95M21.282,020
CEPO
Cantor Equity Partners I
N/A$10.38
+0.3%
N/AN/A$264.69MN/A0.002
SBXD
Silverbox Corp IV
N/A$10.21
-0.1%
N/AN/A$259.90MN/A0.00N/AHigh Trading Volume
RENE
Cartesian Growth Co. II
N/A$11.92
-0.1%
N/A+6.4%$257.61MN/A0.002Short Interest ↑
News Coverage
Positive News
BZAI
Blaize
N/A$2.47
-7.5%
$5.83
+136.2%
N/A$250.93M$1.55M0.00N/A
NREF
NexPoint Real Estate Finance
3.7811 of 5 stars
$14.02
+2.2%
$14.50
+3.5%
+9.3%$247.28M$29.20M13.351Dividend Announcement
Short Interest ↓
News Coverage
TCI
Transcontinental Realty Investors
0.8744 of 5 stars
$27.98
-0.1%
N/A+2.7%$241.68M$44.76M75.61N/AUpcoming Earnings
Analyst Forecast
PINE
Alpine Income Property Trust
3.2219 of 5 stars
$16.56
+0.7%
$19.32
+16.7%
+3.4%$239.72M$52.23M118.29N/AShort Interest ↑
UROY
Uranium Royalty
1.3656 of 5 stars
$1.76
+5.4%
$4.00
+127.3%
-21.4%$235.20M$23.14M58.6910News Coverage

Related Companies and Tools


This page (NASDAQ:AFJK) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners